MedPath

Tomsk National Research Medical Center of the Russian Academy of Sciences

🇷🇺Russia
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

63

Active:3
Completed:45

Trial Phases

5 Phases

Phase 1:14
Phase 2:1
Phase 3:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials

Not Applicable
28 (62.2%)
Phase 1
14 (31.1%)
Phase 2
1 (2.2%)
Phase 3
1 (2.2%)
Phase 4
1 (2.2%)

Personalized Hypoxic-hyperoxic Preconditioning in Elderly People

Not Applicable
Not yet recruiting
Conditions
Preconditioning
Interventions
Drug: Sham treatment
Drug: FiO2 reduced by 20% alternating with 34% FiO2
First Posted Date
2025-06-13
Last Posted Date
2025-06-13
Lead Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Target Recruit Count
20
Registration Number
NCT07018895

Mechanical Dyssynchrony and Microvascular Dysfunction by SPECT

Recruiting
Conditions
Myocardial Blood Flow Reserve
Mechanical Dyssynchrony
Coronary Arterial Disease (CAD)
First Posted Date
2025-05-14
Last Posted Date
2025-05-14
Lead Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Target Recruit Count
75
Registration Number
NCT06969547
Locations
🇷🇺

Tomsk NRMC Cardiology Research Institute, Tomsk, Russian Federation

Mannitol Administration for Delerium Prevention

Active, not recruiting
Conditions
Myocardial Infarction (MI)
Delirium, Intensive Care Unit, Randomised Controlled Trial
First Posted Date
2025-01-06
Last Posted Date
2025-04-09
Lead Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Target Recruit Count
50
Registration Number
NCT06759259
Locations
🇷🇺

Cardiology Reserch Institute Tomsk National Research Centre, Tomsk, Tomskaya Oblast, Russian Federation

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Phase 1
Completed
Conditions
Prostate Cancers
Interventions
Drug: One single intravenous injection of [177Lu]Lu-BQ7876
First Posted Date
2024-10-15
Last Posted Date
2025-04-09
Lead Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Target Recruit Count
7
Registration Number
NCT06641219
Locations
🇷🇺

TomskNRMC, Tomsk, Russian Federation

Intracoronary Hypothermia as a Prevention of Reperfusion Injury in Myocardial Infarction.

Not Applicable
Recruiting
Conditions
Reperfusion Injury
Myocardial Infarction
ST-Elevation Myocardial Infarction (STEMI)
Microvascular Occlusion
First Posted Date
2024-08-22
Last Posted Date
2024-08-22
Lead Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Target Recruit Count
60
Registration Number
NCT06567249
Locations
🇷🇺

Cardiology Research Institute, Tomsk National Research Medical Center, Tomsk, Russian Federation

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.